ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATRA Atara Biotherapeutics Inc

0.7186
0.0212 (3.04%)
After Hours
Last Updated: 17:10:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 833,232
Bid Price 0.7003
Ask Price 0.7294
News -
Day High 0.7243

Low
0.1986

52 Week Range

High
3.015

Day Low 0.6664
Share Name Share Symbol Market Stock Type
Atara Biotherapeutics Inc ATRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0212 3.04% 0.7186 17:10:06
Open Price Low Price High Price Close Price Previous Close
0.6884 0.6664 0.7243 0.7186 0.6974
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,238 833,232 US$ 0.7097166 US$ 591,359 - 0.1986 - 3.015
Last Trade Type Quantity Price Currency
17:02:55 7 US$ 0.7092 USD

Atara Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
73.38M 101.92M - 8.57M -276.13M -2.71 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Atara Biotherapeutics News

Date Time Source News Article
4/05/202415:01Business WireAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
3/28/202407:30Business WireAtara Biotherapeutics Announces Fourth Quarter and Full Year..
3/06/202417:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/04/202419:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/04/202419:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/04/202419:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/29/202408:05Business WireAtara Biotherapeutics Receives FDA Clearance of IND..
2/28/202415:30Business WireAtara Biotherapeutics to Participate in Cell Therapy Panel..
2/23/202415:30Edgar (US Regulatory)Form 8-K - Current report
2/14/202408:00Business WireAtara Biotherapeutics Announces Submission of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATRA Message Board. Create One! See More Posts on ATRA Message Board See More Message Board Posts

Historical ATRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.680.74010.64010.68475341,022,8130.03865.68%
1 Month0.670.83250.61940.71358421,133,0090.04867.25%
3 Months0.60151.580.56860.90169432,819,0440.117119.47%
6 Months1.421.580.19860.6325533,934,708-0.7014-49.39%
1 Year3.003.0150.19860.98675752,738,194-2.28-76.05%
3 Years14.3320.040.19864.221,740,010-13.61-94.99%
5 Years31.6836.550.19866.941,376,711-30.96-97.73%

Atara Biotherapeutics Description

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs.

Your Recent History

Delayed Upgrade Clock